These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 1520635

  • 1. The screening for common drugs of abuse in whole blood by means of EMIT-ETS and FPIA-ADx urine immunoassays.
    Maier RD, Erkens M, Hoenen H, Bogusz M.
    Int J Legal Med; 1992; 105(2):115-9. PubMed ID: 1520635
    [Abstract] [Full Text] [Related]

  • 2. The determination of drugs of abuse in whole blood by means of FPIA and EMIT-dau immunoassays--a comparative study.
    Bogusz M, Aderjan R, Schmitt G, Nadler E, Neureither B.
    Forensic Sci Int; 1990 Nov; 48(1):27-37. PubMed ID: 2279719
    [Abstract] [Full Text] [Related]

  • 3. Performance of immunoassays in screening for opiates, cannabinoids and amphetamines in post-mortem blood.
    Hino Y, Ojanperä I, Rasanen I, Vuori E.
    Forensic Sci Int; 2003 Jan 28; 131(2-3):148-55. PubMed ID: 12590054
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Performance of Abusign drugs-of-abuse slide tests with particluar emphasis on concentrations near the cutoff: comparison with FPIA-ADx and confirmation of results with GC-MS.
    Ros JJ, Pelders MG, Egberts AC.
    J Anal Toxicol; 1998 Jan 28; 22(1):40-4. PubMed ID: 9491967
    [Abstract] [Full Text] [Related]

  • 8. New fluorescence polarization immunoassays for analysis of barbiturates and benzodiazepines in serum and urine: performance characteristics.
    Schwenzer KS, Pearlman R, Tsilimidos M, Salamone SJ, Cannon RC, Wong SH, Gock SB, Jentzen JJ.
    J Anal Toxicol; 2000 Jan 28; 24(8):726-32. PubMed ID: 11110029
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Accuracy of common drug screen tests.
    Schwartz JG, Zollars PR, Okorodudu AO, Carnahan JJ, Wallace JE, Briggs JE.
    Am J Emerg Med; 1991 Mar 28; 9(2):166-70. PubMed ID: 1994947
    [Abstract] [Full Text] [Related]

  • 13. Fluorescence polarization immunoassay for the detection of drugs of abuse in human whole blood.
    Keller T, Schneider A, Dirnhofer R, Jungo R, Meyer W.
    Med Sci Law; 2000 Jul 28; 40(3):258-62. PubMed ID: 10976190
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Direct stopped-flow fluorescence polarization immunoassay of abused drugs and their metabolites in urine.
    Pérez-Bendito D, Gómez-Hens A, Gaikwad A.
    Clin Chem; 1994 Aug 28; 40(8):1489-93. PubMed ID: 8044987
    [Abstract] [Full Text] [Related]

  • 16. Enzyme immunoassay, kinetic microparticle immunoassay, radioimmunoassay, and fluorescence polarization immunoassay compared for drugs-of-abuse screening.
    Armbruster DA, Schwarzhoff RH, Hubster EC, Liserio MK.
    Clin Chem; 1993 Oct 28; 39(10):2137-46. PubMed ID: 8403399
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Abbott phencyclidine and barbiturates abused drug assays: evaluation and comparison of ADx FPIA, TDx FPIA, EMIT, and GC/MS methods.
    Caplan YH, Levine B.
    J Anal Toxicol; 1989 Oct 28; 13(5):289-92. PubMed ID: 2693834
    [Abstract] [Full Text] [Related]

  • 19. Comparative evaluation of five immunoassays for the analysis of alprazolam and triazolam metabolites in urine: effect of lowering the screening and GC-MS cut-off values.
    Fraser AD, Meatherall R.
    J Anal Toxicol; 1996 Oct 28; 20(4):217-23. PubMed ID: 8835658
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.